Avantium starts construction of bio-MEG demonstration plant in the Netherlands
Amsterdam – Avantium N.V., (Euronext Amsterdam and Brussels: AVTX) a leading technology development company and forerunner in renewable chemistry, has started construction of a new demonstration plant that will help advance the production of bio-based mono-ethylene glycol (MEG) made directly from renewable sugars.
As MEG is a component for making everyday consumer goods, such as PET and PEF plastics and polyester textiles, the development of an environmentally friendly plant-based alternative has strong potential. Today, more than 99% of MEG is produced from fossil resources and the market demand for this product is expected to grow from 28 million to 50 million tons in the next 20 years.
“Our novel single-step process can finally fulfil this demand in an environmentally sustainable manner that both consumers and leading brands have been seeking. I am proud of our team for making this important technological breakthrough. This enables renewable products growth for consumers that increasingly demand products brought to them in a responsible manner,” said Tom van Aken, Chief Executive Officer of Avantium.
The new plant will use Avantium’s pioneering Mekong technology to convert renewable sugars into bio-based MEG. The plant – part of a previously disclosed €15-20 million investment in our most advanced technologies – will be operational in 2019, employing up to 20 people.
Alongside this important investment decision by Avantium, the European Innovation Council has selected the Mekong technology as part of its €146 million investment in top-class innovators, entrepreneurs, small companies and scientists with bright ideas and the ambition to scale up internationally. “We are honored to be selected among the 79 innovative projects following face-to-face interviews with a jury of innovators, entrepreneurs and venture capitalists,” said Van Aken.
The objectives of the demonstration plant are to scale up the novel bio-MEG technology, validate the technical and economic feasibility of the process, and to collect data to execute an environmental life-cycle analysis (LCA) quantifying the sustainability benefits of the Avantium technology.
“This is a major step forward in the development of our Mekong technology,” said Zanna McFerson, Chief Business Development Officer of Avantium. “In addition to the environmental benefits, this demonstration plant will replicate commercial scale conditions of producing cost-effective bio-MEG; a drop-in product identical to the fossil-derived product.
We are exploring partnership opportunities in bringing this technology to full-scale commercialization globally.” In parallel to this new development, Avantium is nearing completion of a biorefinery pilot plant for its Zambezi technology that produces high-purity glucose and lignin from non-food
biomass. This biorefinery is located in Delfzijl, the Netherlands.
Investments
Chemical substances
Countries
Companies
Latest news
DSM significantly reduces CO2 emissions at vitamin production facility in Sisseln, Switzerland
DSM announced that it reduces CO2 emissions at its vitamin production facility in Sisseln, Switzerland, by 50,000 tons/year.
Nouryon starts work on chloromethanes expansion in Germany
Nouryon will start construction in May on a project to further increase capacity for chloromethanes at its site in Frankfurt, Germany. The expansion is expected to be completed in 2020.
Ercros expands its moulding compounds production capacity
The Ercros factory in Cerdanyola has expanded the production capacity of moulding compounds by 3,000 t/year, which represents an increase of 14% to reach 25,000 t/year.
Merck Invests in Expansion of Manufacturing Capacity for Biotech Medicines
€150 million investment over the 2019-2023 period in manufacturing site at Aubonne, Switzerland. Expansion supports growth of current and future portfolio of Merck’s biotech medicines for patients ...